255 related articles for article (PubMed ID: 23370355)
1. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
Kurikawa N; Takagi T; Wakimoto S; Uto Y; Terashima H; Kono K; Ogata T; Ohsumi J
Biol Pharm Bull; 2013; 36(2):259-67. PubMed ID: 23370355
[TBL] [Abstract][Full Text] [Related]
2. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
3. Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats.
Uto Y; Ogata T; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Konishi M; Okuyama R; Kurikawa N; Takagi T; Wakimoto S; Ohsumi J
Bioorg Med Chem Lett; 2010 Jan; 20(1):341-5. PubMed ID: 19926281
[TBL] [Abstract][Full Text] [Related]
4. Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases.
Narce M; Bellenger J; Rialland M; Bellenger S
Curr Drug Metab; 2012 Dec; 13(10):1454-63. PubMed ID: 22978399
[TBL] [Abstract][Full Text] [Related]
5. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
6. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
Tamura YO; Sugama J; Iwasaki S; Sasaki M; Yasuno H; Aoyama K; Watanabe M; Erion DM; Yashiro H
J Pharmacol Exp Ther; 2021 Nov; 379(3):280-289. PubMed ID: 34535562
[TBL] [Abstract][Full Text] [Related]
7. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
8. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
Bae CR; Zhang H; Kwon YG
PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
[TBL] [Abstract][Full Text] [Related]
9. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
10. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
12. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
Li H; Ying H; Hu A; Hu Y; Li D
Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
[TBL] [Abstract][Full Text] [Related]
14. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota.
Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
Int Immunopharmacol; 2021 Oct; 99():108065. PubMed ID: 34426119
[TBL] [Abstract][Full Text] [Related]
15. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models.
Miyashita T; Toyoda Y; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
J Toxicol Sci; 2012; 37(5):931-42. PubMed ID: 23038002
[TBL] [Abstract][Full Text] [Related]
19. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
Cheng Y; Chen T; Ping J; Chen J
Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective mechanism of freshwater clam extract alleviates non-alcoholic fatty liver disease: elucidated in vitro and in vivo models.
Lin JJ; Liu YC; Chang CJ; Pan MH; Lee MF; Pan BS
Food Funct; 2018 Dec; 9(12):6315-6325. PubMed ID: 30411763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
